Skip to main content
Premium Trial:

Request an Annual Quote

Diversigen Forms Strategic Alliance With South Korea's BioCore

NEW YORK (GenomeWeb) – Diversigen announced today that it has formed a strategic collaboration with South Korean contract research organization BioCore to help expand its presence in the Asia.

Under the terms of the deal, BioCore will offer Diversigen's microbiome and metagenomics consulting, sequencing, and analysis services to its customers in Korea and other Asian markets. Additional terms of the arrangement were not disclosed.

"BioCore offers the best in a strategic partner — deep domain expertise, a solid reputation, and an innovative approach to serving their customers," Diversigen CEO Caroline Popper said in a statement. "We look forward to helping BioCore and their customers gain competitive advantage through solutions designed to accelerate and transform discovery research, accelerate otherwise lengthy clinical trials, and capitalize on the diverse opportunities of the microbiome."

The deal with BioCore represents the second alliance Diversigen has formed in as many months. In late February, the company signed an agreement with Baylor Miraca Genetics Laboratory to provide their customers with access to their respective targeted genomics and metabolomics services.